{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:12:12Z","timestamp":1790269932733,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd005169","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2008,4,23]],"date-time":"2008-04-23T00:00:00Z","timestamp":1208908800000}}],"reference-count":72,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd005169.pub2","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T05:56:47Z","timestamp":1208757407000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Omega-3 fatty acids for bipolar disorder"],"prefix":"10.1002","volume":"2010","author":[{"given":"Paul","family":"Montgomery","sequence":"first","affiliation":[{"name":"University of Oxford; The Centre for Evidence-Based Intervention; Barnett House 32 Wellington Square Oxford UK OX1 2ER"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra J","family":"Richardson","sequence":"additional","affiliation":[{"name":"University of Oxford; Dept of Physiology, Anatomy and Genetics; Sherrington Building Parks Road Oxford Oxon UK OX1 3PT"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,4,23]]},"reference":[{"issue":"12","key":"10.1002\/14651858.CD005169.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.4088\/JCP.v66n1219b","article-title":"Omega-3 Fatty Acids Are More Beneficial in the Depressive Phase Than in the Manic Phase in Patients With Bipolar I Disorder","volume":"66","author":"Chiu","year":"2005","journal-title":"Journal of Clinical Psychiatry"},{"issue":"4-5","key":"10.1002\/14651858.CD005169.pub2-BIB0002|cit2","first-page":"315","article-title":"Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study","volume":"75","author":"Frangou","year":"2006","journal-title":"British Journal of Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD005169.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.biopsych.2006.03.056","article-title":"Double-Blind, Randomized, Placebo-Controlled Trials of Ethyl-Eicosapentanoate in the Treatment of Bipolar Depression and Rapid Cycling Bipolar Disorder","volume":"60","author":"Kect","year":"2006","journal-title":"Biological Psychiatry"},{"issue":"4-5","key":"10.1002\/14651858.CD005169.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.plefa.2006.07.008","article-title":"Omega-3 fatty acids in bipolar disorder: Clinical and research considerations","volume":"75","author":"Marangell","year":"2006","journal-title":"Prostaglandins, Leukotrienes and Essential Fatty Acids"},{"issue":"5","key":"10.1002\/14651858.CD005169.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1001\/archpsyc.56.5.407","article-title":"Omega 3 Fatty Acids in Bipolar Disorder","volume":"56","author":"Stoll","year":"1999","journal-title":"Archives of General Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1600-0404.1990.tb04490.x","article-title":"Effect of high doses of essential fatty acids on the postviral fatigue syndrome","volume":"82","author":"Behan","year":"1990","journal-title":"Acta Neurologica Scandinavica"},{"issue":"4","key":"10.1002\/14651858.CD005169.pub2-BIB0007|cit7","first-page":"274","article-title":"Phospholipid liposomes in depression: A double-blind study versus placebo","volume":"17","author":"Casacchia","year":"1982","journal-title":"International Pharmacopsychiatry"},{"issue":"2","key":"10.1002\/14651858.CD005169.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1176\/ajp.137.2.242","article-title":"Lecithin in mania: A preliminary report.","volume":"137","author":"Cohen","year":"1980","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0009|cit9","unstructured":"Edwards RW Double blind randomised placebo controlled study of fish oil supplementation in the treatment of common mood disorders (depression\/anxiety) National Research Register 2000"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0022-3956(03)00077-3","article-title":"A placebo-controlled cross-over trial of adjunctive EPA in OCD","volume":"38","author":"Fux","year":"2004","journal-title":"Journal of Psychiatric Research"},{"issue":"1","key":"10.1002\/14651858.CD005169.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1600-0447.1989.tb09234.x","article-title":"A combination of hypothalamic phospholipid liposomes with trazodone for treatment of depression. An open controlled study","volume":"79","author":"Giannelli","year":"1989","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0012|cit12","unstructured":"Gracious B Chirieac MC Youngstrom EA An RCT of flax oil in children and adolescents with bipolar disorder 46th Annual NCDEU (New Clinical Drug Evaluation Unit) Meeting; 2006 June 12 - 15; Boca Raton, FL"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0013|cit13","unstructured":"Gracious BL A comparison of Omega-3 fatty acids vs. placebo in children and adolescents with bipolar disorder controlled-trials.com 2006"},{"issue":"10","key":"10.1002\/14651858.CD005169.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1176\/ajp.161.10.1922","article-title":"Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder","volume":"161","author":"Hirashima","year":"2004","journal-title":"American Journal of Psychiatry"},{"issue":"4","key":"10.1002\/14651858.CD005169.pub2-BIB0015|cit15","first-page":"310","article-title":"Fatty acid concentrations in depressive patients during a repetitive transcranial magnetic stimulation (rTMS)","volume":"24","author":"Irmisch","year":"2005","journal-title":"Nervenheilkunde"},{"issue":"12","key":"10.1002\/14651858.CD005169.pub2-BIB0016|cit16","first-page":"1076","article-title":"Hypothalamic phospholipid liposomes. A drug for the treatment of anxiety-depressive syndromes in internal medicine","volume":"75","author":"Licata","year":"1984","journal-title":"Recenti Progressi in Medicina"},{"issue":"5","key":"10.1002\/14651858.CD005169.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1067\/mob.2003.275","article-title":"Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing","volume":"188","author":"Llorente","year":"2003","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"5","key":"10.1002\/14651858.CD005169.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1176\/appi.ajp.160.5.996","article-title":"A double-blind, placebo-controlled study of the omega-3 fatty acid docosahexaenoic acid in the treatment of major depression","volume":"160","author":"Marangell","year":"2003","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0019|cit19","unstructured":"Marangell LB Zboyan HA Cress KK Benisek D Arterburn L A double-blind, placebo-controlled study of docosahexaenoic acid (DHA) in the treatment of depression 4th Congress of the International Society for the Study of Lipids and Fatty Acids, Tsukuba, Japan 2000"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0020|cit20","unstructured":"Murck H A multicentre, double-blind, randomised, parallel group, placebo-controlled trial of LAX-101 (ethyl eicosapentaenoate) in patients with a new or recurrent episode of depression National Research Register 2004"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0022|cit22","first-page":"149","article-title":"Omega-3 fatty acid treatment of depressive breakthrough during unipolar maintenance","volume":"5 Suppl 1","author":"Nemets","year":"2002","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0023|cit23","first-page":"149","article-title":"Biochemical and clinical effects of treating the premenstrual syndrome with prostaglandin synthesis precursors","volume":"30","author":"Puolakka","year":"1985","journal-title":"Journal of Reproductive Medicine"},{"issue":"2","key":"10.1002\/14651858.CD005169.pub2-BIB0024|cit24","first-page":"105","article-title":"Efficacy and safety of phospholipid liposomes in the treatment of neuropsychological disorders associated with the menopause: A double-blind, randomised, placebo-controlled study","volume":"17","author":"Rachev","year":"2001","journal-title":"Current Medical Research and Opinion"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.plefa.2004.11.004","article-title":"Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression","volume":"72","author":"Silvers","year":"2005","journal-title":"Prostaglandins Leukotrienes and Essential Fatty Acids"},{"issue":"4","key":"10.1002\/14651858.CD005169.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0924-977X(03)00032-4","article-title":"Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial","volume":"13","author":"Su","year":"2003","journal-title":"European Neuropsychopharmacology"},{"issue":"2","key":"10.1002\/14651858.CD005169.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1600-0404.1999.tb00667.x","article-title":"The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA","volume":"99","author":"Warren","year":"1999","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0028|cit28","unstructured":"Olanzapine plus topiramate versus olanzapine plus omega-3 fatty acids for bipolar disorder Ongoing study"},{"issue":"2","key":"10.1002\/14651858.CD005169.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/0165-0327(94)00074-J","article-title":"Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis","volume":"21","author":"Ahrens","year":"1995","journal-title":"Journal of Affective Disorders"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0030|cit30","volume-title":"Diagnostic and Statistical Manual of Mental Disorders (DSM-IV)","author":"American Psychiatric Association","year":"1994"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0031|cit31","first-page":"182","article-title":"Anticonvulsants","volume-title":"Meyler's side effects of drugs. An encyclopaedia of adverse reactions and interactions","author":"Battino","year":"1996"},{"issue":"8","key":"10.1002\/14651858.CD005169.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.1996.03540080059030","article-title":"Improving the quality of reporting of randomized controlled trials. The CONSORT statement","volume":"276","author":"Begg","year":"1996","journal-title":"JAMA"},{"issue":"7108","key":"10.1002\/14651858.CD005169.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/jn\/119.1.15","article-title":"Brain cell and tissue recovery in rats made deficient in n-3 fatty acids by alteration of dietary fat","volume":"119","author":"Bourre","year":"1989","journal-title":"Journal of Nutrition"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1051\/ocl.2003.0165","article-title":"Relations between omega-3, omega-9 fatty acids, structures and brain functions. A review on the latest data. Food financial cost of omega-3","volume":"10","author":"Bourre","year":"2003","journal-title":"Oleagineux Corps Gras Lipides"},{"issue":"6","key":"10.1002\/14651858.CD005169.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1176\/ajp.153.6.765","article-title":"Relation of serum valproate concentration to response in mania","volume":"153","author":"Bowden","year":"1996","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0037|cit37","article-title":"Cochrane Collaboration Handbook","volume-title":"The Cochrane Library","author":"Clarke","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD005169.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"issue":"7109","key":"10.1002\/14651858.CD005169.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","article-title":"A new facility for the measurement of health-related quality of life","volume":"16","author":"The EuroQOL Group","year":"1990","journal-title":"Health Policy"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/10401230009147106","article-title":"Omega-3 fatty acids in psychiatry: a review","volume":"12","author":"Freeman","year":"2000","journal-title":"Annals of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD005169.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.4088\/JCP.v67n1217","article-title":"Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry","volume":"67","author":"Freeman","year":"2006","journal-title":"Journal of Clinical Psychiatry"},{"issue":"9","key":"10.1002\/14651858.CD005169.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from Health Survey for England 1994","volume":"149","author":"Guilliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"Journal of Neurology Neurosurgery and Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD005169.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1176\/appi.ajp.160.12.2222","article-title":"Cross - national comparisons of seafood consumption and rates of bipolar disorders","volume":"160","author":"Noaghiul","year":"2003","journal-title":"American Journal of Psychiatry"},{"issue":"11","key":"10.1002\/14651858.CD005169.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in medicine"},{"issue":"7414","key":"10.1002\/14651858.CD005169.pub2-BIB0047|cit47","first-page":"557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ Clinical Research"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0048|cit48","unstructured":"Higgins JPT Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005] In: The Cochrane Library Chichester, UK: John Wiley & Sons, Ltd."},{"key":"10.1002\/14651858.CD005169.pub2-BIB0049|cit49","first-page":"1282","article-title":"Sodium valproate and neural tube defects","volume":"ii","author":"Jeavons","year":"1982","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD005169.pub2-BIB0050|cit50","first-page":"41","article-title":"'Lithium: The Present and the Future' . A Symposium Report from the American Psychiatric Association Annual Meeting, 1994","volume":"56","author":"Keck","year":"1995","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD005169.pub2-BIB0051|cit51","first-page":"707","article-title":"Neuropsychotropic action of a new antiepileptic: Depramide","volume":"1","author":"Lambert","year":"1966","journal-title":"Annales medico-psychologiques"},{"issue":"1","key":"10.1002\/14651858.CD005169.pub2-BIB0052|cit52","article-title":"Valproate for acute mood episodes in bipolar disorder","author":"Macritchie","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2-3","key":"10.1002\/14651858.CD005169.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-1781(96)02899-5","article-title":"Plasma membrane Phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients:comparison with bipolar patients and normal subjects","volume":"63","author":"Mahadik","year":"1996","journal-title":"Psychiatry Research"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0054|cit54","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"issue":"3 Suppl","key":"10.1002\/14651858.CD005169.pub2-BIB0055|cit55","first-page":"23","article-title":"Valproate in psychiatric disorders: Literature review and clinical guidelines","volume":"50","author":"McElroy","year":"1989","journal-title":"Journal of Clinical Psychiatry"},{"issue":"12","key":"10.1002\/14651858.CD005169.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1176\/ajp.149.12.1633","article-title":"Clinical and research implications of the diagnosis of dysphoric or mixed mania or hypomania","volume":"149","author":"McElroy","year":"1992","journal-title":"American Journal of Psychiatry"},{"issue":"9063","key":"10.1002\/14651858.CD005169.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0140-6736(96)07495-8","article-title":"Global mortality, disability and the contribution of risk factors: Global Burden of Disease Study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1176\/appi.ajp.159.3.477","article-title":"Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder","volume":"159","author":"Nemets","year":"2002","journal-title":"American Journal of Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD005169.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0006-3223(97)00206-0","article-title":"Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients","volume":"43","author":"Peet","year":"1998","journal-title":"Biological Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005169.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3956(01)00048-6","article-title":"A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms","volume":"36","author":"Peet","year":"2002","journal-title":"Journal of Psychiatric Research"},{"issue":"10","key":"10.1002\/14651858.CD005169.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1001\/archpsyc.59.10.913","article-title":"A dose-ranging study of the effects of ethyl-eicosapentaenoate on pateints with ongoing depression despite apparently adequate treatment with standard drugs","volume":"59","author":"Peet","year":"2002","journal-title":"Archives of General Psychiatry"},{"issue":"10","key":"10.1002\/14651858.CD005169.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2165\/00023210-200216100-00004","article-title":"Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience","volume":"16","author":"Perucca","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0063|cit63","first-page":"1","article-title":"Medication treatment of bipolar disorder 2000","volume":"Spec. No","author":"Sachs","year":"2000","journal-title":"Postgraduate Medicine"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000073788","article-title":"Importance of the ratio of omega-6\/omega-3 essential fatty acid evolutionary aspects","volume":"92","author":"Simopoulos","year":"2003","journal-title":"World Review of Nutrition and Diet"},{"issue":"3","key":"10.1002\/14651858.CD005169.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1055\/s-2007-979553","article-title":"Effect of prophylactic treatment on suicide risk in patients with major affective disorders. Data from a randomized prospective trial","volume":"29","author":"Thies-Flechtner","year":"1996","journal-title":"Pharmacopsychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005169.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1017\/S0033291703001107","article-title":"The Inventory of Depressive Symptomatology, clinician rating (IDS-C) and self-report (IDS-SR), and the Quick Inventory Depressive Symptomatology, clinician rating (QIDS-C) and self-report (QIDS-SR) in public sector patients with mood disorders: A psychometric evaluation","volume":"34","author":"Trivedi","year":"2004","journal-title":"Psychological Medicine"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0067|cit67","volume-title":"SF-36 Health Survey: Manual and 1993 Interpretation Guide.","author":"Ware","year":"1993"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0068|cit68","volume-title":"The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines","author":"World Health Organisation","year":"1992"},{"issue":"8","key":"10.1002\/14651858.CD005169.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0006-3223(02)01397-5","article-title":"Correlations between peripheral polyunsaturated fatty acid content and in vivo membrane phospholipid metabolites","volume":"52","author":"Yao","year":"2002","journal-title":"Biological Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD005169.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/(SICI)1097-4547(19990615)56:6<565::AID-JNR2>3.0.CO;2-H","article-title":"Essential fatty acids are mediators of brain biochemistry and cognitive functions","volume":"56","author":"Yehuda","year":"1999","journal-title":"Journal of Neuroscience Research"},{"key":"10.1002\/14651858.CD005169.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD005169.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1176\/appi.ajp.160.1.167","article-title":"Omega-3 fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study","volume":"160","author":"Zanarini","year":"2003","journal-title":"American Journal of Psychiatry"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD005169.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:47:31Z","timestamp":1790268451000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD005169.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Common Mental Disorders Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2008,4,23]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd005169.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4,23]]}}}